-
Most Popular
![Healthcare Stocks Icon](https://investorplace.com/wp-content/uploads/2022/12/healthcare-150x150.png)
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
![The words "recession proof" written on a pink sticky note. bulletproof stocks](https://investorplace.com/wp-content/uploads/2023/07/shutterstock_2170602547-150x150.jpg)
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
![Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks](https://investorplace.com/wp-content/uploads/2024/06/dividend-stocks1600-5-150x150.png)
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
![medicine research, pharmaceutical background, LJPC stock](https://investorplace.com/wp-content/uploads/2022/03/pharmaceuticals_tnxp_1600-150x150.png)
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
Why Is Bluebird Bio (BLUE) Stock Up 17% Today?
Bluebird Bio received a major lift from JPMorgan Chase regarding its gene-editing therapeutic, sending BLUE stock flying.
Why Is ENDRA Life Sciences (NDRA) Stock Down 16% Today?
ENDRA Life Sciences (NDRA) stock is sliding lower on Friday after revealing details of its public offering for 862,500 shares.
Why Is Hillstream BioPharma (HILS) Stock Down 57% Today?
Hillstream BioPharma (HILS) stock is taking a beating on Friday after the company revealed plans for a public offering of its shares.
GSK Stock: A Value Trap or a Hidden Gem?
GSK, formerly known as GlaxoSmithKline, is struggling after a complicated earnings season. Here's why GSK stock is still a buy.
LLY Stock Alert: Mounjaro Takes Eli Lilly to the Next Level
Eli Lilly (LLY) stock is climbing higher on Thursday thanks to a boost from Mounjaro during its earnings report for Q1 2023.
Why Is Baudax Bio (BXRX) Stock Down 52% Today?
Baudax Bio (BXRX) stock is falling hard on Thursday after the pharmaceutical company announced a $4 million public stock offering.
Why Is Evelo Biosciences (EVLO) Stock Up 78% Today?
Evelo Biosciences (EVLO) stock is on the rise Thursday after the company said it's shifting focus toward extracellular vesicle development.
Why Is ZyVersa Therapeutics (ZVSA) Stock Down 46% Today?
ZyVersa Therapeutics (ZVSA) stock is sliding lower on Wednesday following a couple of announcements from the biopharmaceutical company.